Association of aldosterone and cortisol with cardiovascular risk factors in prehypertension stage.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3431092)

Published in Int J Hypertens on August 16, 2012

Authors

Sadiqa Badar Syed1, Masood Anwar Qureshi

Author Affiliations

1: Department of Physiology, Medical and Dental College, Bahria University, Karachi 75260, Pakistan.

Articles cited by this

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45

Sodium and potassium in the pathogenesis of hypertension. N Engl J Med (2007) 5.70

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56

Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res (2005) 2.79

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med (2009) 2.25

Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science (2000) 2.21

The new biology of aldosterone. J Endocrinol (2005) 1.84

Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res (2008) 1.76

Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension (2006) 1.57

Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study. Eur J Epidemiol (2007) 1.52

Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med (2004) 1.46

Mechanisms of mineralocorticoid action. Hypertension (2005) 1.44

Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag (2005) 1.32

Blood pressure, diabetes, and increased dietary salt associated with stroke--results from a community-based study in Pakistan. J Hum Hypertens (2006) 1.32

11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol (2004) 1.29

Mineralocorticoid receptors: distribution and activation. Heart Fail Rev (2005) 1.28

Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol (2006) 1.24

Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes (2002) 1.21

Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension (2004) 1.17

Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol (2005) 1.14

11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes. Diabetologia (2003) 1.00

Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep (2003) 0.98

Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function. Horm Metab Res (2007) 0.95

Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis (2010) 0.94

Amiloride-sensitive Na channels. Curr Opin Cell Biol (1998) 0.89

Factors that influence the risk of hypertension in obese individuals. Curr Opin Nephrol Hypertens (2003) 0.85

Fat tissue metabolism and adrenal steroid secretion. Curr Hypertens Rep (2006) 0.85

Serum potassium is not associated with blood pressure tracking in the Framingham Heart Study. Am J Hypertens (2002) 0.81

An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) (2001) 0.81

Anthropometric and metabolic indicators in hypertensive patients. J Coll Physicians Surg Pak (2009) 0.81

A look to the future: new treatment guidelines and a perspective on statins. Am J Med (2002) 0.78

Gene-lifestyle interactions and their consequences on human health. Med Sport Sci (2009) 0.78

Should we consider aldosterone as the primary screening target for preventing cardiovascular events? J Am Coll Cardiol (2005) 0.77